J&J | JNJ - Ebitda





Ebitda Veränderung Datum
AbbVie USD 3.69B 1.68B 2026-03
Abbott USD 2.43B 844M 2026-03
Amgen USD 3.86B 1.28B 2026-03
AstraZeneca USD 5.16B 510M 2026-06
Baxter International USD 309M 756M 2026-03
Bayer EUR 2.14B 2.31B 2026-06
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Biogen USD 649.7M 76.5M 2026-03
Boston Scientific USD 1.63B 27M 2026-06
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
CONMED USD 78.12M 21.73M 2026-06
Cooper Companies USD 323.4M 13.2M 2025-12
Dexcom USD 364.5M 57.7M 2026-03
Edwards Lifesciences USD 555.6M 485.5M 2026-03
Eli Lilly USD 12.14B 4.26B 2025-12
Gilead Sciences USD 3.51B 489M 2026-03
GlaxoSmithKline GBP 3.51B 734M 2026-06
Globus Medical USD 231.83M 48.62M 2026-03
Insulet USD 181.7M 12.3M 2026-03
Integra LifeSciences USD 78.41M 2.23M 2026-06
Intuitive Surgical USD 1.06B 29.9M 2026-03
J&J USD 8.27B 1.08B 2026-03
Medtronic USD 2.81B 119M 2026-03
Merck USD -1.54B 7.84B 2026-03
Merit Medical Systems USD 104.39M 10.97M 2026-06
Novartis USD 6.48B 1.19B 2026-06
Pfizer USD 5.99B 5.23B 2026-03
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 3.69B 375M 2026-06
Stryker USD 1.93B 357M 2026-06
Tandem Diabetes Care USD 2.73M 30.17M 2026-03
Teva Pharmaceutical Industries USD 474M 581M 2026-06
Vertex Pharmaceuticals USD 1.19B 195.3M 2026-03
Zimmer Biomet Holdings USD 759M 120.8M 2025-12
Zoetis USD 939M 101M 2025-12